FOR Dar es Salaam resident Frank Latamani, the chronic skin condition known as Psoriasis has become not only a painful ordeal ...

Surat: Slamming an insurance firm for rejecting a Covid-19 treatment claim by citing the patient's history of a skin disease, ...

With all that in mind, if you have $2,000 available to invest that isn't needed for monthly bills, to pay down short-term ...

Treatment with envudeucitinib was safe and effective through 52 weeks among patients with with moderate to severe plaque psoriasis.

Mr. Farbstein will present the latest developments in Can-Fite’s advanced stage drug development pipeline including the ...

A ONCE-RARE genital super-fungus that can only be killed off with a ‘toxic’ treatment is now spreading at pace among families ...

The model is accessible, where patients can attend appointments from home, work, or school, without sacrificing hours to ...

Global Monoclonal Antibody Therapeutics Market OverviewThe global monoclonal antibody therapeutics market is poised for substantial expansion, projected to grow at a CAGR of approximately 12% over the ...

Namodenoson, a Phase III cancer drug has strong potential in veterinary oncology, a market projected to reach $3.1 billion by ...

Roman and Ella Wroath, the entrepeneurs behind what was dubbed as the 'UK's Fyre Festival' left clients and traders more than ...

Dear reader, when we discuss the best-selling medications of all time, we’re exploring more than just products with massive sales; we’re highlighting milestones in the ...

The patient, who suffered from advanced liver cancer, was enrolled in Can-Fite's completed Phase II study and continues to be treated with Namodenoson through a compassionate use program. Nine years ...